ADRB2 and open-angle glaucoma: Only the loop II-borne peptides AINCYAN (181–187) and ANETCCD (186–192) abolished the agonistic activity of the AAb from five representative patients with POAG (Figure 5) and, thus, represent the dominant epitope of the β2AR.